News First | Americas

US FDA approves first drug for fatty liver disease NASH

14 March 2024, 12:00 am
1 min read

Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind.